Prostate Cancer E-Health-Tutorial

NCT ID: NCT02503748

Last Updated: 2017-04-24

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 53 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2015-07-31
• Study Completion Date: 2017-02-15

Brief Summary

In a participatory process involving urologists and former patients, the project team has developed an online information system ("tutorial") for patients with localized prostate cancer. In this field test, relevant outcomes are measured and the tutorial will be tested for its clinical applicability.

Detailed Description

Prostate cancer is the most common cancer in men: In Switzerland, every year about 6,000 men are diagnosed with prostate cancer. Men with prostate cancer at an early stage are confronted with a difficult decision: they are faced with different treatment alternatives, each with its own advantages and disadvantages. That is why a comprehensive information delivery and processing is extremely important for patients to make an informed decision.

Therefore, an online platform has been developed in collaboration with urologists and former patients. This online platform is designed to cover the individual information needs of patients with early prostate cancer. Additionally, the software aims at facilitating cooperation between patients and doctors and at increasing the satisfaction of patients with their treatment decision.

In this study, the online platform will now to be tested in clinical practice, and data will be collected for the benefit of the platform: Can the online platform actually satisfy the indivudal information needs, facilitate the therapy decision and support the cooperation between doctors and patients?

Conditions

Prostate Cancer

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Intervention

Online Tutorial

Group Type: EXPERIMENTAL

Online tutorial

Intervention Type: OTHER

website informing about treatment options in localized prostate cancer

Interventions

Online tutorial

website informing about treatment options in localized prostate cancer

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• tumor stage: clinical stage T1 or T2
• PSA level <20 (PSA = Prostata-specific antigen)
• Gleason score <8
• age ≤ 75 years
• Assumed life expectancy ≥ 10 years

• patients have to be diagnosed in one of the trial sites
• Internet-enabled device in the patient's household / basal user knowledge of this device
• signing of the consent form

Exclusion Criteria

• Impaired judgment
• Insufficient ability to read and understand German
• Emotional problems

• Maximum Eligible Age: 75 Years
• Eligible Sex: MALE
• Accepts Healthy Volunteers: No

Sponsors

Zurich University of Applied Sciences

OTHER

Sponsor Role: lead

Responsible Party

René Schaffert

lic.phil.

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

René Schaffert, lic. phil.

Role: PRINCIPAL_INVESTIGATOR

Zurich University of Applied Sciences

Locations

Urologische Universitätsklinik Basel, Kantonsspital Basselland

Liestal, Basel-Landschaft, Switzerland

UrologieZentrum Bern

Bern, Canton of Bern, Switzerland

Klinik für Urologie, Luzerner Kantonsspital

Lucerne, Canton of Lucerne, Switzerland

Urologisches Kompetenzzentrum soH

Olten, Canton of Solothurn, Switzerland

Klinik für Urologie, Kantonsspital St. Gallen

Sankt Gallen, Canton of St. Gallen, Switzerland

Klinik für Urologie, Stadtspital Triemli

Zurich, Canton of Zurich, Switzerland

Urologie, Kantonsspital Graubünden

Chur, Kanton Graubünden, Switzerland

Urologische Klinik, Kantonsspital Münsterlingen

Münsterlingen, Thurgau, Switzerland

Countries

Switzerland

Other Identifiers

ZH 2015-132

Identifier Type: -

Identifier Source: org_study_id